The Atrial fibrillation Better Care (ABC) pathway and cardiac complications in atrial fibrillation: a potential sex-based difference. The ATHERO-AF study-Reference-Cited by-同舟云学术

The Atrial fibrillation Better Care (ABC) pathway and cardiac complications in atrial fibrillation: a potential sex-based difference. The ATHERO-AF study

Published:2021-03 Issue: Volume:85 Page:80-85
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Pastori Daniele^ORCID,Menichelli Danilo,Violi Francesco,Pignatelli Pasquale,Y H Lip Gregory

Publisher

Elsevier BV

Subject

Internal Medicine

Reference28 articles.

1. Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF;Pokorney;J Am Heart Assoc,2016

2. Atrial fibrillation and incident myocardial infarction in the elderly;O’Neal;Clin Cardiol,2014

3. Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study;Chao;Heart Rhythm,2014

4. Should atrial fibrillation patients with only 1 nongender-related CHA2DS2-VASc risk factor be anticoagulated?;Fauchier;Stroke,2016

5. Atrial fibrillation and the risk of myocardial infarction;Soliman;JAMA Intern. Med.,2014

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adherence to the atrial fibrillation better care pathway and its associated factors among rural patients with atrial fibrillation in China: A cross-sectional study;Heart & Lung;2024-06

2. Understanding for whom, under what conditions, and how an integrated approach to atrial fibrillation service delivery works: a realist review;European Journal of Cardiovascular Nursing;2024-01-02

3. Renin‐angiotensin-aldosterone system inhibitors and mortality risk in elderly patients with atrial fibrillation. Insights from the nationwide START registry;European Journal of Internal Medicine;2024-01

4. Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registry;Nutrition, Metabolism and Cardiovascular Diseases;2023-11

5. 2023 ESC Guidelines for the management of cardiomyopathies;European Heart Journal;2023-08-25